Cariprazine in Three Special Different Areas: A Real-World Experience

Cariprazine is an antipsychotic medication which received approval from the US Food and Drug Administration for the treatment of schizophrenia in September 2015. Cariprazine is a dopamine D(3) and D(2) receptor partial agonist, with a preference for the D(3) receptor. Furthermore, although to a more...

Descripción completa

Detalles Bibliográficos
Autores principales: Gesi, Camilla, Paletta, Silvia, Palazzo, Maria Carlotta, Dell’Osso, Bernardo, Mencacci, Claudio, Cerveri, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665865/
https://www.ncbi.nlm.nih.gov/pubmed/34908838
http://dx.doi.org/10.2147/NDT.S335332